Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

Anne W Rimoin, Prime M Mulembakani, Sara C Johnston, James O Lloyd Smith, Neville K Kisalu, Timothee L Kinkela, Seth Blumberg, Henri A Thomassen, Brian L Pike, Joseph N Fair, Nathan D Wolfe, Robert L Shongo, Barney S Graham, Pierre Formenty, Emile Okitolonda, Lisa E Hensley, Hermann Meyer, Linda L Wright, Jean-Jacques Muyembe, Anne W Rimoin, Prime M Mulembakani, Sara C Johnston, James O Lloyd Smith, Neville K Kisalu, Timothee L Kinkela, Seth Blumberg, Henri A Thomassen, Brian L Pike, Joseph N Fair, Nathan D Wolfe, Robert L Shongo, Barney S Graham, Pierre Formenty, Emile Okitolonda, Lisa E Hensley, Hermann Meyer, Linda L Wright, Jean-Jacques Muyembe

Abstract

Studies on the burden of human monkeypox in the Democratic Republic of the Congo (DRC) were last conducted from 1981 to 1986. Since then, the population that is immunologically naïve to orthopoxviruses has increased significantly due to cessation of mass smallpox vaccination campaigns. To assess the current risk of infection, we analyzed human monkeypox incidence trends in a monkeypox-enzootic region. Active, population-based surveillance was conducted in nine health zones in central DRC. Epidemiologic data and biological samples were obtained from suspected cases. Cumulative incidence (per 10,000 population) and major determinants of infection were compared with data from active surveillance in similar regions from 1981 to 1986. Between November 2005 and November 2007, 760 laboratory-confirmed human monkeypox cases were identified in participating health zones. The average annual cumulative incidence across zones was 5.53 per 10,000 (2.18-14.42). Factors associated with increased risk of infection included: living in forested areas, male gender, age < 15, and no prior smallpox vaccination. Vaccinated persons had a 5.2-fold lower risk of monkeypox than unvaccinated persons (0.78 vs. 4.05 per 10,000). Comparison of active surveillance data in the same health zone from the 1980s (0.72 per 10,000) and 2006-07 (14.42 per 10,000) suggests a 20-fold increase in human monkeypox incidence. Thirty years after mass smallpox vaccination campaigns ceased, human monkeypox incidence has dramatically increased in rural DRC. Improved surveillance and epidemiological analysis is needed to better assess the public health burden and develop strategies for reducing the risk of wider spread of infection.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Typical clinical presentation of human monkeypox in a 7-y-old female child, Sankuru District, Democratic Republic of Congo.
Fig. 2.
Fig. 2.
Map of health zones with active surveillance for human monkeypox, designated by dominant ecological characteristics, Sankuru District, Democratic Republic of Congo: 2006–2007. Zones are shaded by dominant ecological characteristics: dark green, heavily forested zone; red, ecotone (forest–savannah mosaic); yellow, savannah.
Fig. 3.
Fig. 3.
Average annual cumulative incidence of human monkeypox, by health zone and dominant ecological characteristic, Sankuru District, Democratic Republic of Congo: 2006–2007. Cumulative incidence and 95% CIs are shown for each major geographical area. Ecotone is a transitional zone of mosaic forests interspersed with stretches of savannah between savannah and forest regions.
Fig. 4.
Fig. 4.
Comparison of average annual cumulative incidence of human monkeypox by age group Kole Health Zone, Demographic Republic of Congo: 1981–86 vs. 2006–7. *, proportion of the population vaccinated in 2006–7 and in 1981–6 based on vaccination scar surveys in 1981–6 and in 2006. ^, vaccination rate steadily declined from 41.0% in 1981 to 4% in 1985 (13, 33).

References

    1. Arita I, Henderson DA. Smallpox and monkeypox in non-human primates. Bull World Health Organ. 1968;39:277–283.
    1. Breman JG, et al. Human monkeypox, 1970-79. Bull World Health Organ. 1980;58:165–182.
    1. Hutin YJ, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001;7:434–438.
    1. Jezek Z, et al. Serological survey for human monkeypox infections in a selected population in Zaire. J Trop Med Hyg. 1987;90:31–38.
    1. Learned LA, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. 2005;73:428–434.
    1. Lourie B, et al. Human infection with monkeypox virus: Laboratory investigation of six cases in West Africa. Bull World Health Organ. 1972;46:633–639.
    1. Damon IK, Roth CE, Chowdhary V. Discovery of monkeypox in Sudan. N Engl J Med. 2006;355:962–963.
    1. Reed KD, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342–350.
    1. Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet. 1986;1:98–99.
    1. Khodakevich L, et al. The role of squirrels in sustaining monkeypox virus transmission. Trop Geogr Med. 1987;39:115–122.
    1. Khodakevich L, et al. Monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire. Trop Geogr Med. 1987;39:56–63.
    1. WHO . The Global Eradication of Smallpox: Final Report of the Global Commission for the Certification of Smallpox Eradication. Geneva: World Heath Organization; 1980.
    1. Jezek Z, Fenner F. Human Monkeypox. Basel: Karger; 1988.
    1. Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17:643–650.
    1. Jezek Z, Grab B, Dixon H. Stochastic model for interhuman spread of monkeypox. Am J Epidemiol. 1987;126:1082–1092.
    1. Anonymous The current status of human monkeypox: Memorandum from a WHO meeting. Bull World Health Organ. 1984;62:703–713.
    1. Khodakevich L, Jezek Z, Messinger D. Monkeypox virus: Ecology and public health significance. Bull World Health Organ. 1988;66:747–752.
    1. Hammarlund E, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005;11:1005–1011.
    1. Kile JC, et al. Transmission of monkeypox among persons exposed to infected prairie dogs in Indiana in 2003. Arch Pediatr Adolesc Med. 2005;159:1022–1025.
    1. Xiao SY, et al. Experimental infection of prairie dogs with monkeypox virus. Emerg Infect Dis. 2005;11:539–545.
    1. Chen N, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 2005;340:46–63.
    1. Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M. LC16m8: An attenuated smallpox vaccine. Vaccine. 2006;24:7009–7022.
    1. Parrino J, et al. VRC 201/203 Study Team Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals. Vaccine. 2007;25:1513–1525.
    1. Ministère de la Sante de la République Démocratique du Congo . Recensement Annuel de la Population par Zone de Sante. Insititut National de la Statistique, Kinshasa; 2009.
    1. Colyn M, Dudu A, Mbaelele M. Proceedings of International Symposium on Wildlife Utilization in Africa, eds IGF/CIC. Zimbabwe: Harare; 1987. Data on small and medium scale game utilization in the rainforest in Zaire; pp. 109–141.
    1. Olson VA, et al. Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol. 2004;42:1940–1946.
    1. Kulesh DA, et al. Smallpox and pan-orthopox virus detection by real-time 3′-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms. J Clin Microbiol. 2004;42:601–609.
    1. Kulesh DA, et al. Monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan assays on the Roche LightCycler. Lab Invest. 2004;84:1200–1208.
    1. Ministry of Health DRoC . Census of the Population of Zaire: 1984. Kinshasa: Ministry of Health, Democratic Republic of Congo; 1984.
    1. Breslow NE, Day NE, editors. Statistical Methods in Cancer Research. Volume II–The Design and Analysis of Cohort Studies. France: World Health Org, Lyon; 1987.
    1. Orenstein WA, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63:1055–1068.
    1. StataCorp . Stata Statistical Software: Release 10. College Station, TX: StataCorp LP; 2007.
    1. Jezek Z, Grab B, Paluku KM, Szczeniowski MV. Human monkeypox: Disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop Geogr Med. 1988;40:73–83.

Source: PubMed

3
Abonner